WELL Health Technologies reports $368.3M Q1 revenue, beating estimates by $1.92M, with Adjusted EBITDA up 56% year-over-year.
WELL Health Technologies posted Q1 revenue of $368.3M, exceeding estimates by $1.92M and marking a 25.2% year-over-year increase. Non-GAAP EPS matched expectations at $0.06.
The company’s Adjusted EBITDA rose 56% to $43.1 million from Q1 2025, reflecting strong margin expansion. WELL reaffirmed its fiscal 2026 outlook, signaling confidence in sustained growth.
Shares showed muted reaction in after-hours trading as investors digested the results.